Scaffold Translation: Barriers Between Concept and Clinic
- 1 December 2011
- journal article
- review article
- Published by Mary Ann Liebert Inc in Tissue Engineering, Part B: Reviews
- Vol. 17 (6), 459-474
- https://doi.org/10.1089/ten.teb.2011.0251
Abstract
Translation of scaffold-based bone tissue engineering (BTE) therapies to clinical use remains, bluntly, a failure. This dearth of translated tissue engineering therapies (including scaffolds) remains despite 25 years of research, research funding totaling hundreds of millions of dollars, over 12,000 papers on BTE and over 2000 papers on BTE scaffolds alone in the past 10 years (PubMed search). Enabling scaffold translation requires first an understanding of the challenges, and second, addressing the complete range of these challenges. There are the obvious technical challenges of designing, manufacturing, and functionalizing scaffolds to fill the Form, Fixation, Function, and Formation needs of bone defect repair. However, these technical solutions should be targeted to specific clinical indications (e.g., mandibular defects, spine fusion, long bone defects, etc.). Further, technical solutions should also address business challenges, including the need to obtain regulatory approval, meet specific market needs, and obtain private investment to develop products, again for specific clinical indications. Finally, these business and technical challenges present a much different model than the typical research paradigm, presenting the field with philosophical challenges in terms of publishing and funding priorities that should be addressed as well. In this article, we review in detail the technical, business, and philosophical barriers of translating scaffolds from Concept to Clinic. We argue that envisioning and engineering scaffolds as modular systems with a sliding scale of complexity offers the best path to addressing these translational challenges.Keywords
This publication has 183 references indexed in Scilit:
- Chemically-Conjugated Bone Morphogenetic Protein-2 on Three-Dimensional Polycaprolactone Scaffolds Stimulates Osteogenic Activity in Bone Marrow Stromal CellsTissue Engineering, Part A, 2010
- Sustained plasmid DNA release from dissolving mineral coatingsActa Biomaterialia, 2010
- Mechanical and microstructural properties of polycaprolactone scaffolds with one-dimensional, two-dimensional, and three-dimensional orthogonally oriented porous architectures produced by selective laser sinteringActa Biomaterialia, 2010
- Modular peptides promote human mesenchymal stem cell differentiation on biomaterial surfacesActa Biomaterialia, 2010
- Complications of Recombinant Human BMP-2 for Treating Complex Tibial Plateau Fractures: A Preliminary ReportClinical Orthopaedics and Related Research, 2009
- Modular Peptide Growth Factors for Substrate‐Mediated Stem Cell DifferentiationAngewandte Chemie, 2009
- Growth of Hydroxyapatite Coatings on Biodegradable Polymer MicrospheresACS Applied Materials & Interfaces, 2009
- A tissue engineering approach to bone repair in large animal models and in clinical practiceBiomaterials, 2007
- Complications of anterior cervical discectomy and fusion using recombinant human bone morphogenetic protein-2European Spine Journal, 2007
- Modularity and community structure in networksProceedings of the National Academy of Sciences of the United States of America, 2006